Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Rayonier Advanced Materials Q4 2025 Earnings Call - Deliver Positive Free Cash Flow in 2026
New CEO Scott Sutton laid out a surgical, urgent plan: fix the cash burn first, then lift value across cellulose specialties and every business line. RYAM reported negative free cash flow of $88 milli...
- RYAM generated negative free cash flow of $88 million in 2025, and management calls the combination of cash burn plus high-cost debt unsustainable.
- Top priority is clear and public: deliver positive free cash flow in 2026, with every group treating it as mission critical.
- 85% of Cellulose Specialties volumes are now under contracts averaging an 18% price increase, but those deals carry an expected roughly 20% volume decline versus 2025.
- +12 more takeaways
Abercrombie & Fitch 4th Quarter Fiscal Year 2025 Earnings Call - Record FY25 Sales and Double-Digit Margins, but Tariffs and ERP Create Near-Term Headwinds
Abercrombie & Fitch closed fiscal 2025 with record revenue and robust profitability, proving the company can scale. Full-year net sales topped $5.27 billion, driven by broad-based growth at Hollister ...
- Fiscal 2025 was a record year: net sales $5.27 billion, up about 6% year over year, the first time ANF surpassed $5 billion.
- Q4 net sales were $1.67 billion, up 5% versus last year, with comparable sales roughly +1% and balanced growth across regions, brands, and channels.
- Hollister was the growth engine: fiscal year net sales up 15% with comparable sales +13%, and Q4 marked the brand's 11th consecutive quarter of growth.
- +12 more takeaways
NexGen Energy Q4 2025 Earnings Call - Project Ready to Start Construction Pending Final Federal Approval and CAD 1.1B Cash
NexGen says it is poised to transition Rook One from development to construction once final federal approval arrives, after completing the two-part Canadian Nuclear Safety Commission hearings and rece...
- CNSC process effectively complete, staff have recommended approval after two-part hearings, opening the path to final federal sign-off and construction consent.
- NexGen finished 2025 with approximately CAD 1.1 billion in cash, after a CAD 950 million equity raise, providing runway for the first year of construction.
- Management reiterates a CAD 2.2 billion total CapEx estimate for Rook One, stating no material movement despite inflationary pressure.
- +11 more takeaways
Wix Q4 2025 Earnings Call - Base44 hits ~$100M ARR as Harmony lifts cohorts and management doubles down with $2B buyback
Wix closed 2025 with solid growth and a headline breakout: Base44, acquired less than a year earlier, scaled to roughly $100 million of ARR, rapidly expanding Wix’s total addressable market from websi...
- Base44 breakout: Base44 reached approximately $100 million of ARR within months of acquisition, positioning it among the fastest-growing software platforms in history.
- Wix Harmony traction: Harmony, launched in English in January, is already improving new-cohort conversion, ARPU, and monetization, and management plans to make it the default experience over time.
- Aggressive capital return: Wix expects to complete the large majority of its $2 billion repurchase program this year, citing conviction that the stock undervalues its long-term opportunity.
- +16 more takeaways
Wallbox Q4 2025 Earnings Call - Margins Improve; Refinancing Nears Completion, Growth Hinges on Sales Rebuild
Wallbox closed 2025 with clear operational progress and persistent top-line strain. Full-year revenue fell to EUR 145.1 million, down 11% year-over-year, while unit deliveries were roughly 144,000. Ma...
- Full-year 2025 revenue: EUR 145.1 million, down 11% year-over-year, with roughly 144,000 units delivered (536 DC units).
- Adjusted EBITDA improved 51% year-over-year to a loss of EUR 29.5 million, showing significant operating leverage progress.
- Gross margin expanded to 38.3% for FY2025, a 410 basis point improvement, driven by bill-of-materials cost reductions and pricing.
- +12 more takeaways
Altisource Portfolio Solutions Q4 2025 Earnings Call - Sales Wins and Hubzu Inventory Surge Should Offset Rithm and Onity Roll-offs
Altisource closed 2025 with revenue gains, modest margin improvement, and a string of sales wins that management says will blunt the impact of Rithm and Onity business roll-offs. Service revenue rose,...
- Full year 2025 service revenue rose 7% to $161.3 million, driven by sales wins across both segments.
- Total company adjusted EBITDA improved 5% to $18.3 million for 2025, while business segment adjusted EBITDA rose 7% to $47.6 million.
- GAAP loss before income taxes improved to $14.1 million in 2025, from a $32.9 million loss in 2024, largely due to lower interest expense after a capital structure change.
- +15 more takeaways
The Real Brokerage Q4 2025 Earnings Call - Platform scale delivers positive cash flow and narrowing losses despite mix headwinds
Real closed 2025 with scale. Q4 revenue rose 44% to $505 million and full-year revenue topped nearly $2.0 billion, driven by a 38% surge in closed transactions in Q4 and a 31% year-over-year increase ...
- Q4 revenue rose 44% year-over-year to $505 million; full-year 2025 revenue was nearly $2.0 billion, up 56% from 2024.
- Closed transactions in Q4 increased 38% to nearly 49,000; full-year transactions exceeded 185,000.
- Agent base grew 31% year-over-year to 31,739 at year-end 2025 and is now over 33,000 agents on the platform.
- +12 more takeaways
GitLab Fourth Quarter Fiscal 2026 Earnings Call - Launches Duo Agent Platform, guides conservatively while investing to reaccelerate growth
GitLab closed FY26 with ARR above $1 billion, revenue of $955 million, and free cash flow of $220 million, but management is shading FY27 guidance while doubling down on five focused growth levers: re...
- GitLab surpassed $1 billion ARR in FY26, with FY26 revenue of $955 million, up 26% year over year.
- FY26 adjusted free cash flow was $220 million, up about 83%, and non GAAP operating margin reached 17% for the year.
- Q4 revenue was $260 million, up 23% year over year, beating guidance by ~3.5 points, aided by ~$3 million of one time FX and Jihu items.
- +12 more takeaways
QuickLogic Corporation Q4 2025 Earnings Call - SRH Test Chips and $13M Government Tranche Set Stage for 2026 Revenue Ramp
QuickLogic closed Q4 fiscal 2025 with $3.7 million in revenue, a sharp QoQ bounce but still down 35% year over year, and finished the quarter with $18.8 million in cash, including a $15 million credit...
- Q4 revenue was $3.7 million, down 35% YoY but up 84% QoQ, split $2.8 million new product and $0.9 million mature product revenue.
- Non-GAAP gross margin was 20.8% in Q4, pressured by $473k inventory reserves and $135k of professional services costs booked to COGS.
- Non-GAAP operating expenses in Q4 were $3.5 million, about $500k above prior outlook due to executive incentive accruals; non-GAAP net loss was $2.9 million, or $0.17 per share.
- +12 more takeaways
ImmunityBio Full Year 2025 Earnings Call - ANKTIVA Commercial Ramp: $113M Revenue and Global Expansion, But Cash Burn and Regulatory Hurdles Persist
ImmunityBio frames 2025 as a turning point, driven by the commercial launch of ANKTIVA. The company reported $113 million in ANKTIVA net product revenue, a 700% year-over-year jump, broad internationa...
- ANKTIVA commercialization accelerated in 2025, generating $113.0 million in net product revenue versus $14.1 million in 2024, a 700% year-over-year increase driven largely by U.S. uptake.
- Unit sales rose approximately 750% year-over-year, and sequential revenue grew 20% from Q3 to Q4 2025, signaling adoption momentum not solely reliant on price.
- ANKTIVA is authorized in 33 countries, including the U.S., U.K., EU (conditional marketing authorization Feb 2026), and Saudi Arabia, where Saudi FDA uniquely approved ANKTIVA in combination with checkpoint inhibitors for metastatic NSCLC.
- +11 more takeaways